fashion -WSS

fashion

author：knowledge 2025-09-09 05:35:28 - browse：35385

Medicare is planning to send $9 billion in lump sum payments to more than 1,600 hospitals that participate in a drug discount program. Adobe

WASHINGTON — Medicare is planning to send $9 billion in lump-sum payments to more than 1,600 hospitals that participate in a drug discount program after the Supreme Court found the program underpaid them for prescription drugs, the agency announced on Friday.

To pay for the restitution, Medicare would slash all hospitals’ payments for other items and services by 0.5% for the next 16 years.

The remedy accounts for four years of underpayments to hospitals that participate in the 340B drug discount program. The Trump administration dramatically reduced Medicare payments for discounted drugs in 2018, but the Supreme Court found they didn’t follow the proper procedure and that the payment scheme was illegal.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Caitlin Bernard's story shows physicians can't shy from advocacy

focus

hotspot

WSS

How artificial intelligence is being used to detect, treat cancer

Physicians aren't 'burning out.' They're suffering from moral injury

Artificial intelligence advances fuel industry trying to preserve loved ones after death

The a glaring gap in research on serious mental illness and primary care

H.R. 3 is the wrong path to lower drug costs

How artificial intelligence is being used to detect, treat cancer

hotspot

fashion

focus

What does generative AI mean for health care? We asked experts

Court strikes down limits on filming of police in Arizona

BioMarin wins approval for gene therapy to treat hemophilia A

A controversial new treatment promises to make little people taller

Hollywood unions extend contract negotiations for actors

FDA official pushes for dedicated emerging pathogens team

Heart attack and stroke risk calculators need revising

FDA scientists endorse Pfizer/BioNTech Covid

Activists slam private health insurers over coverage restrictions

How artificial intelligence is being used to detect, treat cancer

knowledge

Caitlin Bernard's story shows physicians can't shy from advocacy

A controversial new treatment promises to make little people taller

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Biotech startup Celsius cuts 75% of staff ahead of first trial start

FDA approves Sage Therapeutics’ rapid

Group behind ProMed defends move to subscription

focus

focus

hotspot

hotspot